Emergent BioSolutions (NYSE:EBS) Coverage Initiated by Analysts at HC Wainwright
HC Wainwright began coverage on shares of Emergent BioSolutions (NYSE:EBS – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The brokerage issued a buy rating and a $15.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts have also issued research reports about the stock. StockNews.com lowered shares […]
More Stories
Deere Tops Earnings Estimates, Reaffirms Focus on US Manufacturing
By Panos Mourdoukoutas John Deere’s revenue and earnings dropped in the second quarter of fiscal year 2025 due to a...
Supreme Court Wrestles With Nationwide Injunctions in Birthright Citizenship Cases
By Sam Dorman The Supreme Court on May 15 grappled with how far federal judges could go in issuing sweeping...
US Pending Home Sales Dip By 3.4 Percent to ‘Lowest Level on Record’: Report
By Naveen Athrappully Pending home sales in the United States declined by 3.4 percent year over year during the four...
Jayson Tatum Carried Off Floor With Right Leg Injury and Celtics Star Will Have MRI
By The Associated Press NEW YORK—The Boston Celtics are used to seeing Jayson Tatum get up when he goes down,...
What Startups Need to Know Before Building Their First Software Product
You have a good idea for a software product. If you are an entrepreneur and startup founder, you are eager...
TreeHouse Foods, Inc. (NYSE:THS) Stock Position Raised by Northern Trust Corp
Northern Trust Corp lifted its holdings in shares of TreeHouse Foods, Inc. (NYSE:THS – Free Report) by 5.9% in the...